December 7, 2023
Virtual Clinical Trials Market

Virtual Clinical Trials Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Technology and Growing Demand for Patient-Centric Approach

The Virtual Clinical Trials Market is estimated to be valued at US$ 2,260.61 Mn in 2023 and is expected to exhibit a CAGR of 17.65% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Virtual clinical trials refer to the conduct of various clinical trial activities using digital technology such as smartphones, wearable devices, and electronic health records. This approach eliminates the need for physical sites and visits, reducing costs, improving patient participation, and enabling remote monitoring. Virtual clinical trials offer several benefits such as increased patient recruitment, enhanced data quality, reduced time for trial completion, and improved patient experience. These trials are particularly effective in rare disease studies, pediatric trials, and remote population studies.

Market Dynamics:
The virtual clinical trials market is driven by the increasing adoption of technology in clinical research and the growing demand for a patient-centric approach. The integration of advanced technologies such as artificial intelligence, data analytics, and cloud computing has transformed the traditional clinical trial process, making it more efficient and cost-effective. Additionally, virtual trials enable efficient patient recruitment and retention by providing access to a larger patient pool and reducing geographic barriers. Furthermore, the COVID-19 pandemic has accelerated the adoption of virtual clinical trials as they offer a safer alternative to traditional in-person trials. These factors are expected to drive the growth of the virtual clinical trials market over the forecast period.

Segment Analysis:

Virtual Clinical Trials Market Growth  can be segmented based on the type of virtual trial, services, and end-users. In terms of virtual trial type, the dominating segment is the intervention virtual trial. This is due to the increasing adoption of intervention virtual trials by pharmaceutical companies and CROs for testing the efficacy and safety of new drugs and treatments. Intervention virtual trials involve active participation of subjects and require direct intervention from researchers or healthcare professionals. They offer advantages such as reduced recruitment time, lower costs, and improved patient engagement.

PEST Analysis:

Political: The political factors influencing the virtual clinical trials market include regulations and policies related to medical research and data privacy. Governments play a crucial role in shaping the regulatory framework for virtual trials, ensuring ethical standards are met, and protecting patient privacy.

Economic: The economic factors driving the virtual clinical trials market include cost savings associated with reduced site visits, shorter timelines, and increased efficiency. Virtual trials eliminate the need for extensive infrastructure and travel expenses, making them a cost-effective option for both pharmaceutical companies and patients.

Social: The social factors impacting the virtual clinical trials market include patient convenience and increased participation. Virtual trials offer flexibility in terms of location and time, reducing the burden on patients and allowing them to participate from the comfort of their homes. This leads to higher patient recruitment and retention rates.

Technological: The technological factors contributing to the growth of the virtual clinical trials market include advancements in telemedicine, wearable devices, and digital health platforms. These technologies enable remote monitoring, data collection, and real-time communication between researchers, patients, and healthcare professionals.

Key Takeaways:

The global virtual clinical trials market is expected to witness high growth, exhibiting a CAGR of 17.65% between 2023 and 2030. This growth is primarily driven by the increasing adoption of virtual trials by pharmaceutical companies and CROs due to the advantages they offer in terms of cost savings, efficiency, and patient engagement.

In terms of regional analysis, North America is the fastest-growing and dominating region in the virtual clinical trials market. The presence of major pharmaceutical companies, a well-established research infrastructure, and favorable government initiatives contribute to the growth of this region.

Key players operating in the virtual clinical trials market include Delve Health, Clario, Clinical Ink, Castor, Accenture, Thread, Science 37, Medable, Dassault Systèmes, and eElinicalHealth (CLINPAL), among others. These key players offer various technology and service solutions to support virtual trials, ensuring efficient data collection, analysis, and patient engagement.